SCHEMBL27911496

SCHEMBL27911496

CNCC(C)(CC(C)(C)OC(N)=O)c1cc(Br)ccc1F

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DGAT1 O75907 1/20 0.34
▸ PTGDR2 Q9Y5Y4 1/20 0.34
▸ RBP4 P02753 1/20 0.34
▸ AAK1 Q2M2I8 2/20 0.33
▸ PTGFR P43088 5/20 0.32
▸ MAP2K1 Q02750 1/20 0.31
▸ NPC1 O15118 2/20 0.31
▸ RAB9A P51151 2/20 0.31
▸ BRD4 O60885 1/20 0.31
▸ BRD2 P25440 1/20 0.31
▸ BRD3 Q15059 1/20 0.31
▸ BRDT Q58F21 1/20 0.31
▸ PTPN7 P35236 1/20 0.31
▸ DUSP3 P51452 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27911493 0.89 DGAT1 (0.36) DGAT1PTGDR2RBP4AAK1PTGFR
SCHEMBL27911530 0.79 SMN1; SMN2 (0.35) ALDH1A1MAPK1SMN1; SMN2
SCHEMBL27894286 0.79 DGAT1 (0.35) DGAT1PTGDR2RBP4AAK1
SCHEMBL12614516 0.76 DGAT1 (0.44) DGAT1PTGDR2RBP4AAK1MAP2K1
SCHEMBL27911497 0.71 SMN1; SMN2 (0.41) PTGDR2RBP4AAK1NPC1RAB9A
SCHEMBL244454 0.71 AAK1 (0.48) PTGDR2RBP4AAK1NPC1RAB9A
SCHEMBL27698022 0.70 DGAT1 (0.44) DGAT1AAK1
SCHEMBL27893710 0.69 PARP1 (0.36) SMN1; SMN2
SCHEMBL27893711 0.69 PARP1 (0.36) SMN1; SMN2
SCHEMBL27828850 0.69 RAB9A (0.38) PTGDR2AAK1RAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102985412-A 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatement of alzheimer's disease and other forms of dementia JANSSEN PHARMACEUTICA NV 2013-03-20 — — CN disclosed
Send feedback